Press Releases from PNS Pharma (125 total)
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than…
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than…
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight
“Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Herceptin drug in clinical pipeline. Currently…
Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight
“Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight” report by PNS Pharma gives comprehensive clinical insight on 37 biosimilar version of Lantus drug in…
Remicade (Infliximab) Biosimilar Clinical Trial Insight
“Remicade (Infliximab) Biosimilar Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 17 biosimilar version of Remicade drug in clinical pipeline. Currently…
Agenus-Cancer Drugs Clinical Pipeline Insight
“Agenus-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Agenus. This report highlights various clinical…
Ajinomoto - Cancer Drugs Clinical Pipeline Insight
“Ajinomoto - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Ajinomoto. This report highlights…
Alnylam Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Alnylam Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Alnylam. This report…
Alphamab - Cancer Drugs Clinical Pipeline Insight
“Alphamab - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Alphamab. This report highlights…
Antigenics - Cancer Drugs Clinical Pipeline Insight
“Antigenics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Antigenics. This report highlights…
Karolinska Institute - Cancer Drugs Clinical Pipeline Insight
“Karolinska Institute - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Karolinska Institute. This…
Kyowa Hakko Kirin - Cancer Clinical Pipeline Insight
“Kyowa Hakko Kirin - Cancer Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Kyowa Hakko Kirin.…
Leo Pharma - Cancer Drugs Clinical Pipeline Insight
“Leo Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Leo Pharma. This…
MabVax Therapeutics - Cancer Drugs Clinical Pipeline Insight
“MabVax Therapeutics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by MabVax Therapeutics. This…
Macrogenics - Cancer Drugs Clinical Pipeline Insight
“Macrogenics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Macrogenics. This report highlights…
MGI Pharma - Cancer Drugs Clinical Pipeline Insight
“MGI Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by MGI Pharma. This…
Morphosys - Cancer Drugs Clinical Pipeline Insight
“Morphosys - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Morphosys. This report highlights…
Morphtek - Cancer Drugs Clinical Pipeline Insight
“Morphtek - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Morphtek. This report highlights…
Nippon Kayaku - Cancer Drugs Clinical Pipeline Insight
“Nippon Kayaku - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Nippon Kayaku. This…
OPKO Health - Cancer Drugs Clinical Pipeline Insight
“OPKO Health - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by OPKO Health. This…
Otsuka Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Otsuka Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Otsuka Pharmaceuticals. This…
Peregrine Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Peregrine Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Peregrine Pharmaceuticals. This…
Plexxikon - Cancer Drugs Clinical Pipeline Insight
“Plexxikon - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Plexxikon. This report highlights…
Progenics Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Progenics Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Progenics Pharmaceuticals. This…
Samyang Group - Cancer Drugs Clinical Pipeline Insight
“Samyang Group - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Samyang Group. This…
Go To Page: 1 2
